Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.81 – $3.35
53% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $67.1K | $748.4K | $1.3M | $1.5M | $2.3M | $2.5M | $3.1M | $4.5M |
| Cost of revenue | $28.6K | $524.5K | $1.9M | $770.7K | $880.0K | $864.1K | $1.2M | $2.1M |
| Gross profit | $38.5K | $223.9K | −$578.4K | $695.1K | $1.4M | $1.6M | $1.9M | $2.4M |
| Gross margin | 57.4% | 29.9% | -45.3% | 47.4% | 60.9% | 65.2% | 61.4% | 53.7% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$507.5K | −$939.9K | −$2.1M | −$1.9M | −$911.6K | −$2.2M | −$183.1K | −$943.9K |
| EBITDA | −$2.0M | $728.8K | −$2.5M | −$1.9M | −$910.7K | −$2.2M | −$183.1K | −$791.7K |
| Net income | −$3.3M | $632.8K | −$2.6M | −$2.0M | −$983.1K | −$2.5M | −$840.7K | −$881.1K |
| Net margin | -4959.7% | 84.6% | -201.8% | -135.6% | -43.7% | -99.5% | -27.0% | -19.5% |
| EPS (diluted) | -145.40 | 0.69 | -1.34 | -0.75 | -0.34 | -0.85 | -0.28 | -0.09 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $14M | $0.13 | $0.13–$0.13 | 1 |
Forward consensus · source: Financial Modeling Prep
HEALTHY EXTRACTS INC
No one on the platform currently holds HYEX.
No tracked institution reports a position in HYEX as of their last filing.
| Execution date | Ratio |
|---|---|
| 2023-12-29 | 1-for-120reverse |
No one on the platform has traded HYEX yet.
| $3M |
| — |
| CRRTFCrescita Therapeutics, Inc. | $0.56 | +0.00% | $10M | — |
| CVSICV Sciences, Inc. | $0.02 | +0.00% | $4M | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 1.9× sales vs its 7.1× historical median P/S.
Fair value ≈ $8.08 · price $2.15 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$HYEX Outstanding article that hits the mark on HYEX's current state. So if you want to refresh your HYEX insights or learn about HYEX from scratch, this is a must read. https://everyticker.com/quote/HYEX/analysis/healthy-extracts-gummy-gamble-growth-acceleration-meets-going-concern-risk-otcqb-hyex
View on StockTwits ↗$HYEX Excellent article that nails exactly where HYEX stands right now. So if you want to update your HYEX knowledge or get acquainted with HYEX, this is a must read. https://beyondspx.com/quote/HYEX/analysis/healthy-extracts-gummy-gamble-growth-acceleration-meets-going-concern-risk-otcqb-hyex
View on StockTwits ↗$HYEX This is now trading 2 dollars cheaper than a few months ago. What gives?
View on StockTwits ↗$HYEX new CEO of Healthy Extracts™ Inc. discussed in an exclusive interview with the Money Channel the company's recent transformative merger with Gummy USA https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/healthy-extracts-ceo-highlights-accelerating-growth-through-gummy-1079808
View on StockTwits ↗$HYEX Healthy Extracts CEO Highlights Accelerating Growth Through Gummy USA Merger and Technology in Money Channel Interview https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/healthy-extracts-ceo-highlights-accelerating-growth-through-gummy-1079808
View on StockTwits ↗$HYEX Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger With $GELS Partnership & product Launch https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/healthy-extracts-builds-upon-record-q2-results-and-transformative-1068668
View on StockTwits ↗$GELS nobody is buying $HYEX so $GELS is worthless.
View on StockTwits ↗$HYEX Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/healthy-extracts-builds-upon-record-q2-results-and-transformative-1068668
View on StockTwits ↗$HYEX Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs $GELS https://www.accessnewswire.com/newsroom/en/computers-technology-and-internet/healthy-extracts-builds-upon-record-q2-results-and-transformative-1068668
View on StockTwits ↗$HYEX Really good write-up that perfectly summarizes HYEX's present situation. So if you want to bring your HYEX knowledge up to date or just discover HYEX, this is required reading. https://beyondspx.com/quote/HYEX/healthy-extracts-catalyzing-growth-through-innovation-and-strategic-expansion-otcqb-hyex#analysis
View on StockTwits ↗$AABB $BKTPF $CRUZ $HYEX status confirmed! 😂😉🐵🤴👍🏾🥔xoxo gossip girl.
View on StockTwits ↗$CRUZ $BKTPF $HYEX $AABB add Me as a Leader and hit notifications bell
View on StockTwits ↗@GaryCruz244 $CRUZ $BKTPF $HYEX $AABB ok I'm done sharing tickers want to know tickers im watching that you should be watching too just bisit my profile and see My Posts! Hope this Helps Tremendously!
View on StockTwits ↗$GELS agreement with $HYEX is old news. We are still shorting this heavy.
View on StockTwits ↗Yesterday's Recap: $BSAI Letter of Intent to Acquire 25 Acres $HYEX Acquires Precision-Dosed Nutraceutical Gummy Technology $AREB Second National Media Blitz $SPARF $SPRK.C New Pegmatite Zones with Lithium Pathfinders
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.